We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

How Genomics is Shaping Advanced Therapeutics

Article   Jan 29, 2019 | By Natasha Beeton-Kempen, Ph.D., Freelance Science Writer, Editor, and Consultant

 
How Genomics is Shaping Advanced Therapeutics
 
 
 

RELATED ARTICLES

Pluripotent Stem Cells in Drug Discovery: Can We Stem the Tide of Unsuccessful Drugs?

Article

Stem cells were first discovered in human cord blood in 1978. Why would we think they can be of more help now? This article delves into reasons behind the sudden interest in stem cells, and highlights how they can be used to advance drug discovery.

READ MORE

Realizing the Potential of Top-down Proteomics

Article

Having grown beyond early ‘proof-of-principle’ studies, top-down proteomics is now extensively used to analyze intact proteins in numerous applications. Here, we discuss how the top-down proteomics approach emerged, reasons underpinning its success, and highlight some of the most exciting current developments.

READ MORE

Addressing Controversy in ADHD: An Interview with Russell A. Barkley, PhD

Article

We interviewed Russell A. Barkley, PhD, an internationally recognized expert on attention-deficit hyperactivity disorder (ADHD), to gain an insight into the disorder, its portrayal in the media and the future of ADHD research.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE